Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 9, 2004British Journal of CancerOpen Access

Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy

View Full Paper
Ask AI
Bookmark
Share

Authors

WYWinnie YeoChinese University of Hong KongBZBenny ZeeChinese University of Hong KongSZSen ZhongShanghai Ninth People's Hospital

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Yeo et al. (2004) studied this question.

synapsesocial.com/papers/6a8579624f2eb4dbc91e5c6dhttps://doi.org/10.1038/sj.bjc.6601699
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1High hepatitis B virus (HBV) DNA viral load is an important risk factor for HBV reactivation in breast cancer patients undergoing cytotoxic chemotherapy2004 · 99 citations
  2. 2Prophylactic lamivudine prevents hepatitis B reactivation in chemotherapy patients2002 · 68 citations
  3. 3Sequence variations of precore/core and precore promoter regions of hepatitis B virus in patients with or without viral reactivation during cytotoxic chemotherapy2000 · 40 citations
  4. 4Acute Liver Decompensation on Withdrawal of Cytotoxic Chemotherapy and Immunosuppressive Therapy in Hepatitis B Carriers1989 · 89 citations